Eli Lilly & Co.
(NYSE : LLY)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc. -0.74%53.590.9%$1398.09m
JNJJohnson & Johnson -0.07%179.340.7%$1295.00m
BMYBristol-Myers Squibb Co. -2.43%75.711.0%$1182.79m
MRKMerck & Co., Inc. 0.13%92.430.7%$1168.42m
ABBVAbbVie, Inc. -1.61%148.151.9%$1082.69m
LLYEli Lilly & Co. 1.62%318.541.1%$982.89m
AZNAstraZeneca Plc 0.53%67.051.0%$494.08m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. 0.15%143.390.0%$493.30m
NVSNovartis AG -0.11%91.160.2%$259.56m
GSKGlaxoSmithKline Plc -1.09%43.940.2%$254.81m
VERUVeru, Inc. -1.15%12.500.0%$250.90m
HZNPHorizon Therapeutics Plc 3.83%94.065.4%$203.54m
SGENSeagen Inc. 2.78%142.315.7%$190.83m
NVONovo Nordisk A/S 0.53%107.160.1%$183.82m
VTRSViatris, Inc. 1.25%12.160.0%$167.33m

Company Profile

Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. The firm's products consist of Diabetes, Oncology, Immunology, Neuroscience, and Other therapies. The Diabetes products include Baqsimi, Basaglar, Humalog, Humulin, Jardiance, Lyumjev, Trajenta, and Trulicity. The Oncology products consist of Alimta, Cyramza, Erbitux, Retevmo, Tyvyt, and Verzenio. The Immunology products include Olumiant and Taltz. The Neuroscience products consist of Cymbalta, Emgality, Reyvow, and Zyprexa. The Other therapies include Bamlanivimab, Cialis, and Forteo. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.